Review





Similar Products

93
MedChemExpress p300 activator ctb
P300 Activator Ctb, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p300 activator ctb/product/MedChemExpress
Average 93 stars, based on 1 article reviews
p300 activator ctb - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Hasegawa Co Ltd histone acetyltransferase activity of p300
Histone Acetyltransferase Activity Of P300, supplied by Hasegawa Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/histone acetyltransferase activity of p300/product/Hasegawa Co Ltd
Average 90 stars, based on 1 article reviews
histone acetyltransferase activity of p300 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Active Motif p300 active motif 61401 antibody
P300 Active Motif 61401 Antibody, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p300 active motif 61401 antibody/product/Active Motif
Average 90 stars, based on 1 article reviews
p300 active motif 61401 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Genmed Inc p300/cbp-hat activity photometric assay kit
P300/Cbp Hat Activity Photometric Assay Kit, supplied by Genmed Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p300/cbp-hat activity photometric assay kit/product/Genmed Inc
Average 90 stars, based on 1 article reviews
p300/cbp-hat activity photometric assay kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Selleck Chemicals p300 activator ctb
HDAC3 and <t>p300</t> play roles in regulating of MeCP2 lactylation in ischemic stroke. A) Western blot analysis of MeCP2 lactylation at K210 and K249 in cortical samples from MCAO mice treated with saline or RGFP966. B) Quantification of GVI PLA2 and PDCD4 expression levels in the saline or RGFP966‐treated MCAO mice ( n = 6 per group). C) Representative images of TTC staining showing RGFP966 reduced infarct volume of MCAO mice. D) Quantification of brain infarct volume in mice treated with saline and RGFP966 at 1 d and 3 d post‐MCAO ( n = 5–7 per group). E) Evaluation of grip strength, F) mNSS scores, and G) fault step ratio in stroke mice treated with saline and RGFP966 ( n = 6–7 per group). H) Western blot analysis showing the effect of <t>CTB</t> treatment on MeCP2 lactylation at K210 and K249 compared to saline. I) Quantification of GVI PLA2 and PDCD4 expression levels in mice treated with saline or CTB ( n = 3 per group). J) Representative images of brain sections stained for infarction from mice treated with saline or CTB. K) Quantification of brain infarct volume in mice treated with saline or CTB ( n = 5–7 per group). L) Grip strength test, M) mNSS scores, and N) fault step ratio for mice treated with saline or CTB ( n = 9–10 per group). Modified Neurological Severity Scores (F, M) are shown as median ± ranges, and other values are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
P300 Activator Ctb, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p300 activator ctb/product/Selleck Chemicals
Average 90 stars, based on 1 article reviews
p300 activator ctb - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Active Motif recombinant full-length active p300
HDAC3 and <t>p300</t> play roles in regulating of MeCP2 lactylation in ischemic stroke. A) Western blot analysis of MeCP2 lactylation at K210 and K249 in cortical samples from MCAO mice treated with saline or RGFP966. B) Quantification of GVI PLA2 and PDCD4 expression levels in the saline or RGFP966‐treated MCAO mice ( n = 6 per group). C) Representative images of TTC staining showing RGFP966 reduced infarct volume of MCAO mice. D) Quantification of brain infarct volume in mice treated with saline and RGFP966 at 1 d and 3 d post‐MCAO ( n = 5–7 per group). E) Evaluation of grip strength, F) mNSS scores, and G) fault step ratio in stroke mice treated with saline and RGFP966 ( n = 6–7 per group). H) Western blot analysis showing the effect of <t>CTB</t> treatment on MeCP2 lactylation at K210 and K249 compared to saline. I) Quantification of GVI PLA2 and PDCD4 expression levels in mice treated with saline or CTB ( n = 3 per group). J) Representative images of brain sections stained for infarction from mice treated with saline or CTB. K) Quantification of brain infarct volume in mice treated with saline or CTB ( n = 5–7 per group). L) Grip strength test, M) mNSS scores, and N) fault step ratio for mice treated with saline or CTB ( n = 9–10 per group). Modified Neurological Severity Scores (F, M) are shown as median ± ranges, and other values are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
Recombinant Full Length Active P300, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant full-length active p300/product/Active Motif
Average 90 stars, based on 1 article reviews
recombinant full-length active p300 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

95
Boster Bio p300 cbp activity assays evaluation
HDAC3 and <t>p300</t> play roles in regulating of MeCP2 lactylation in ischemic stroke. A) Western blot analysis of MeCP2 lactylation at K210 and K249 in cortical samples from MCAO mice treated with saline or RGFP966. B) Quantification of GVI PLA2 and PDCD4 expression levels in the saline or RGFP966‐treated MCAO mice ( n = 6 per group). C) Representative images of TTC staining showing RGFP966 reduced infarct volume of MCAO mice. D) Quantification of brain infarct volume in mice treated with saline and RGFP966 at 1 d and 3 d post‐MCAO ( n = 5–7 per group). E) Evaluation of grip strength, F) mNSS scores, and G) fault step ratio in stroke mice treated with saline and RGFP966 ( n = 6–7 per group). H) Western blot analysis showing the effect of <t>CTB</t> treatment on MeCP2 lactylation at K210 and K249 compared to saline. I) Quantification of GVI PLA2 and PDCD4 expression levels in mice treated with saline or CTB ( n = 3 per group). J) Representative images of brain sections stained for infarction from mice treated with saline or CTB. K) Quantification of brain infarct volume in mice treated with saline or CTB ( n = 5–7 per group). L) Grip strength test, M) mNSS scores, and N) fault step ratio for mice treated with saline or CTB ( n = 9–10 per group). Modified Neurological Severity Scores (F, M) are shown as median ± ranges, and other values are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
P300 Cbp Activity Assays Evaluation, supplied by Boster Bio, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p300 cbp activity assays evaluation/product/Boster Bio
Average 95 stars, based on 1 article reviews
p300 cbp activity assays evaluation - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
Active Motif p300 active motif antibody
HDAC3 and <t>p300</t> play roles in regulating of MeCP2 lactylation in ischemic stroke. A) Western blot analysis of MeCP2 lactylation at K210 and K249 in cortical samples from MCAO mice treated with saline or RGFP966. B) Quantification of GVI PLA2 and PDCD4 expression levels in the saline or RGFP966‐treated MCAO mice ( n = 6 per group). C) Representative images of TTC staining showing RGFP966 reduced infarct volume of MCAO mice. D) Quantification of brain infarct volume in mice treated with saline and RGFP966 at 1 d and 3 d post‐MCAO ( n = 5–7 per group). E) Evaluation of grip strength, F) mNSS scores, and G) fault step ratio in stroke mice treated with saline and RGFP966 ( n = 6–7 per group). H) Western blot analysis showing the effect of <t>CTB</t> treatment on MeCP2 lactylation at K210 and K249 compared to saline. I) Quantification of GVI PLA2 and PDCD4 expression levels in mice treated with saline or CTB ( n = 3 per group). J) Representative images of brain sections stained for infarction from mice treated with saline or CTB. K) Quantification of brain infarct volume in mice treated with saline or CTB ( n = 5–7 per group). L) Grip strength test, M) mNSS scores, and N) fault step ratio for mice treated with saline or CTB ( n = 9–10 per group). Modified Neurological Severity Scores (F, M) are shown as median ± ranges, and other values are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
P300 Active Motif Antibody, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p300 active motif antibody/product/Active Motif
Average 90 stars, based on 1 article reviews
p300 active motif antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
MedChemExpress ctb p300 activator cat
HDAC3 and <t>p300</t> play roles in regulating of MeCP2 lactylation in ischemic stroke. A) Western blot analysis of MeCP2 lactylation at K210 and K249 in cortical samples from MCAO mice treated with saline or RGFP966. B) Quantification of GVI PLA2 and PDCD4 expression levels in the saline or RGFP966‐treated MCAO mice ( n = 6 per group). C) Representative images of TTC staining showing RGFP966 reduced infarct volume of MCAO mice. D) Quantification of brain infarct volume in mice treated with saline and RGFP966 at 1 d and 3 d post‐MCAO ( n = 5–7 per group). E) Evaluation of grip strength, F) mNSS scores, and G) fault step ratio in stroke mice treated with saline and RGFP966 ( n = 6–7 per group). H) Western blot analysis showing the effect of <t>CTB</t> treatment on MeCP2 lactylation at K210 and K249 compared to saline. I) Quantification of GVI PLA2 and PDCD4 expression levels in mice treated with saline or CTB ( n = 3 per group). J) Representative images of brain sections stained for infarction from mice treated with saline or CTB. K) Quantification of brain infarct volume in mice treated with saline or CTB ( n = 5–7 per group). L) Grip strength test, M) mNSS scores, and N) fault step ratio for mice treated with saline or CTB ( n = 9–10 per group). Modified Neurological Severity Scores (F, M) are shown as median ± ranges, and other values are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
Ctb P300 Activator Cat, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctb p300 activator cat/product/MedChemExpress
Average 94 stars, based on 1 article reviews
ctb p300 activator cat - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


HDAC3 and p300 play roles in regulating of MeCP2 lactylation in ischemic stroke. A) Western blot analysis of MeCP2 lactylation at K210 and K249 in cortical samples from MCAO mice treated with saline or RGFP966. B) Quantification of GVI PLA2 and PDCD4 expression levels in the saline or RGFP966‐treated MCAO mice ( n = 6 per group). C) Representative images of TTC staining showing RGFP966 reduced infarct volume of MCAO mice. D) Quantification of brain infarct volume in mice treated with saline and RGFP966 at 1 d and 3 d post‐MCAO ( n = 5–7 per group). E) Evaluation of grip strength, F) mNSS scores, and G) fault step ratio in stroke mice treated with saline and RGFP966 ( n = 6–7 per group). H) Western blot analysis showing the effect of CTB treatment on MeCP2 lactylation at K210 and K249 compared to saline. I) Quantification of GVI PLA2 and PDCD4 expression levels in mice treated with saline or CTB ( n = 3 per group). J) Representative images of brain sections stained for infarction from mice treated with saline or CTB. K) Quantification of brain infarct volume in mice treated with saline or CTB ( n = 5–7 per group). L) Grip strength test, M) mNSS scores, and N) fault step ratio for mice treated with saline or CTB ( n = 9–10 per group). Modified Neurological Severity Scores (F, M) are shown as median ± ranges, and other values are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

Journal: Advanced Science

Article Title: MeCP2 Lactylation Protects against Ischemic Brain Injury by Transcriptionally Regulating Neuronal Apoptosis

doi: 10.1002/advs.202415309

Figure Lengend Snippet: HDAC3 and p300 play roles in regulating of MeCP2 lactylation in ischemic stroke. A) Western blot analysis of MeCP2 lactylation at K210 and K249 in cortical samples from MCAO mice treated with saline or RGFP966. B) Quantification of GVI PLA2 and PDCD4 expression levels in the saline or RGFP966‐treated MCAO mice ( n = 6 per group). C) Representative images of TTC staining showing RGFP966 reduced infarct volume of MCAO mice. D) Quantification of brain infarct volume in mice treated with saline and RGFP966 at 1 d and 3 d post‐MCAO ( n = 5–7 per group). E) Evaluation of grip strength, F) mNSS scores, and G) fault step ratio in stroke mice treated with saline and RGFP966 ( n = 6–7 per group). H) Western blot analysis showing the effect of CTB treatment on MeCP2 lactylation at K210 and K249 compared to saline. I) Quantification of GVI PLA2 and PDCD4 expression levels in mice treated with saline or CTB ( n = 3 per group). J) Representative images of brain sections stained for infarction from mice treated with saline or CTB. K) Quantification of brain infarct volume in mice treated with saline or CTB ( n = 5–7 per group). L) Grip strength test, M) mNSS scores, and N) fault step ratio for mice treated with saline or CTB ( n = 9–10 per group). Modified Neurological Severity Scores (F, M) are shown as median ± ranges, and other values are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

Article Snippet: [ ] Additionally, 30 μmol kg −1 of the p300 activator CTB (Cat. E1107, Selleck, USA) or 10 mg kg −1 RGFP966 (Cat. S7229, Selleck, USA) was intraperitoneally injected 12 h post‐MCAO.

Techniques: Western Blot, Saline, Expressing, Staining, Modification